Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This editorial highlights the potential superiority of older pulse-waveform analysis methods over newer cuff-based indices for assessing arterial stiffness and predicting cardiovascular risk.
The past 20 years have seen reintroduction of older (noncuff) techniques for measurement of arterial stiffness, including pulse-wave velocity (PWV) from delay of the wave foot (as used by Nobel Laureate A.V. Hill), and pulse-waveform analysis, as applied by Marey, Mahomed, and Mackenzie more than 100 years ago.1 A recent consensus document2 summarizes the present status, with aortic PWV regarded as “gold standard,” and pulse-waveform analysis as a simple useful adjunct in epidemiologic and drug studies and in clinical practice. This work has been extended to generate central aortic pressure waves as more precise indices of aortic stiffening and the effects of stiffening on cardiac and arterial function.3 Cuff methods have also been extended in recent times, so as to generate new indices of arterial stiffness, which may be useful in predicting risk and in epidemiologic studies. These were aided by introduction of ambulatory blood-pressure (BP) monitoring during a full 24-h period. The best-tested index is the “ambulatory arterial stiffness index (AASI),” which relates cuff systolic to diastolic pressures. The AASI has been shown well correlated with “aortic” PWV and an independent predictor of mortality. In this issue of the journal, Gosse and colleagues4 compare AASI with two other cuff methods for gauging arterial stiffness—the relation of pulse pressure to mean pressure (PP/MBP slope) and the “QKD100-60,” which is a time delay between the onset of the electrocardiogram (ECG) QRS and the last Korotkov sound at the brachial cuff, after multiple adjustments. Potential of the methods is apparent as their relationship with each other, with cardiovascular events in univariate analysis, and QKD100-60 with events in multivariate analysis. Where do all the techniques stand in clinical practice? Apart from innate and unexplained inaccuracy of all cuff methods when compared with intra-arterial pressures,1 successful reports of AASI and QKD100-60 have required 50 or more measures during a 24-h period. Even the Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation (SAMPLE) study,5 which showed marginal superiority of ambulatory over clinic BP for reduction of left-ventricular mass in hypertensives, required cuff inflation every 15 min by day and 20 min at night. Editorialists, such as Stephane Laurent, point out the ease with which aortic PWV can be measured and ask why this gold standard2 is not used instead; I agree. But the older methods of pulse-waveform analysis may prove even better for subjects with normal ventricular function who have received no drug therapy—such as those reported in this issue by Gosse et al. In such subjects, reduction in left-ventricular mass was better predicted by change in the pulse waveform than by change in any cuff measure or by reduction in aortic PWV.6 For a century or more, the cuff sphygmomanometer has dominated clinicians’ attention. Despite advances, such as described by Gosse et al, modification of pulse-waveform methods may prove more useful. Practitioners need keep an open mind. Michael F. O’Rourke is a founding director of AtCor Medical, manufacturer of pulse-wave analysis systems.
No takes yet. Share an insight, caveat, or question.
M OROURKE (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: